Introduction
Murine acquired immunodeficiency syndrome (MAIDS) is macrophages in the absence of B cells (10). In a previous study, we and others demonstrated that X chromosome-linked a disease characterized by abnormal lymphoproliferation, polyclonal T and B cell activation, enhanced production of immunodeficient (XID) mice, which have a single amino acid substitution in the pleckstrin homology domain of Bruton's cytokines, hypergammaglobulinemia, including a vast elevation of IgG2a and severe immunodeficiency, with death occurtyrosine kinase (Btk) (16) and lack functionally mature B cells ring at 15-20 weeks after infection (1-3). The development (17) (18) (19) (20) (21) (22) , show a delayed progression of MAIDS (12, 23) . of MAIDS is caused by infection of susceptible strains of However, the cellular mechanisms of this delayed progression mice, such as C57BL/6 (B6) mice, with a mixture of LP-BM5 of MAIDS in XID mice are still unclear. murine leukemia virus (MuLV). The virus mixture contains
In this study, we examined the susceptibility of XID mice to non-pathogenic replication-competent MuLV and a disease-MAIDS by transferring B cells from wild-type mice that have inducing defective virus (4-6). The progression of disease is developed MAIDS. We have found that XID mice become a consequence of complex host-virus interactions that are fully susceptible to MAIDS when B cells from wild-type mice only partially understood. The presence of both CD4 ϩ T cells with MAIDS are transplanted and that cells from asymptomatic and B cells is critical for the development of this disease (7, 8) .
XID mice are also effective in the transmission of the disease to It has been reported that the majority of cells infected with B6 mice. Finally, we discuss the role of a B cell subpopulation LP-BM5 MuLV belong to B-lineage cells (6,9-12), although lacking in XID mice that triggers the progression of MAIDS. peritoneal macrophages (13) and T cells (14, 15) can serve as targets for infection. Using mice with a B cell deficiency Methods due to a targeted mutation of the membrane exon of the IgM Mice heavy chain gene, it has been shown that B cells are the primary target for infection and expression of defective C57BL/6 (B6) female mice were purchased from Japan SLC (Hamamatsu, Japan). C57BL/6.xid (XID) mice were virus, and that there is inefficient infection of T cells and maintained in the animal facility at the Institute of Medical T cells in the B cell-enriched population was Ͻ2% and that of B cells in the T cell-enriched population was~12%. Cells Science, University of Tokyo, under specific pathogen-free conditions. BALB.B and C57BL/6-Ly5.1-Pep 3b (B6-Ly5.1) obtained were transferred into XID or B6 mice i.p. and the development of MAIDS in the mice was followed. mice were kindly provided by Dr J. Hayakawa (Kanazawa University, Kanazawa, Japan) and Dr T. Takahashi (Aichi Evaluation of MAIDS development Cancer Center, Nagoya, Japan) respectively.
We examined for development of MAIDS on the basis of LP-BM5 MuLV splenomegaly, hypergammaglobulinemia and suppressed proliferative responsiveness of lymphoid cells to concanavalin A SC-1 clone chronically infected with LP-BM5 MuLV, termed the G6 cell line, kindly supplied by Dr H. C. Morse, III (National A (Con A) as previously described (3). The serum level of IgG2a was determined by isotype-specific ELISA according Institutes of Health, Bethesda, MD), has been maintained by Dr T. Mizuochi (Japanese National Institute of Health). The to the procedures described below. Con A response was assessed by [ 3 H]thymidine incorporation into spleen cells as virus was prepared from the supernatant of G6 cells as previously described (3) and was kindly provided by Dr described below. T. Mizuochi. The virus preparation (~5ϫ10 4 p.f.u. ecotropic ELISA virus/ml) was stored at -70°C until use.
Serum concentrations of IgG2a of Igh b and Igh a allotypes in Antibodies for flow cytometry each group of mice were quantitated by ELISA using flatbottomed flexible 96-well trays (Becton Dickinson) coated The following mAb were used: RA3-6B2 mAb, which recognizes B220 (ATCC, Rockville, MD); 53-7.3 mAb, which with anti-mouse IgG2a mAb (5.7; PharMingen, San Diego, CA) for Igh b allotype and anti-mouse IgG2a mAb (Southern recognizes Ly-1 (ATCC); and 2.4G2 mAb, which recognizes murine FcγR (ATCC). A37-501 mAb, which recognizes Ly5.1, Biotechnology Associates, San Francisco, CA) for Igh a allotype respectively (3). Sera were diluted 3-fold starting at and 104.2 mAb, which recognizes Ly5.2, were kindly provided by Dr K. Mitani (Meiji Institute of Health Science, Odawara, 1:500 and incubated with antibody at room temperature for 2 h. After washing, biotinylated goat anti-mouse IgG mAb Japan) and Dr H. Yakura (Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan) respectively.
(PharMingen) was added to each well and the plates were incubated for another 2 h at room temperature. Then horse-FACS analysis of CD5 ϩ B cells in B6 mice with MAIDS radish peroxidase-streptavidin (Zymed) was added to each well and incubated for 30 min at room temperature. Finally, For FACS analysis of CD5 ϩ B cells, cells in peritoneal washouts (PEC), peripheral lymph node or spleen were prepared from o-phenylenediamine and hydrogen peroxide were added to each well. The enzyme reaction was stopped by adding B6 mice infected with LP-BM5 MuLV at various times postinfection. These cells were stained with biotinylated antisulfuric acid and the optical density at 495 nm was determined with a V-max Kinetic Micro Plate Reader (Molecular Devices, Ly-1 (CD5) mAb plus phycoerythrin (PE)-labeled streptavidin (Gibco/BRL, Gaithersburg, MD) and FITC-labeled anti-B220 Menlo Park, CA). Using purified mouse IgG2a, (8.3 mAb, PharMingen), standard curves were generated and concenmAb. Non-specific Fc-mediated binding of antibody was blocked by addition of unlabeled anti-FcγR mAb to cells trations were determined with a computer program, SOFTmax (Molecular Devices). before incubation with the labeled reagents. Analyses were carried out on a FACScan (Becton Dickinson, Mountain View, Proliferative response to Con A CA) equipped with an argon laser (480 nm), operating at 200 mW. Only cells within the lymphocyte gate were counted Proliferative responses of spleen cells to Con A were measured as previously described (3). Briefly, spleen cells (1ϫ10 5 / as previously described (12) .
200 µl) were cultured in RPMI 1640 medium supplemented Reconstitution of XID mice with CD5 ϩ B cells with 8% FCS, 5ϫ10 -5 M 2-mercaptoethanol, streptomycin (100 µg/ml) and penicillin (100 U/ml) in 96-well microplates PEC (2ϫ10 6 ) from non-infected B6 mice were transferred i.p. into XID mice. Nine weeks after the transfer, PEC from the for 3 days with Con A (2 µg/ml). Cultures were set up in triplicates. Proliferative response was assessed on the basis recipient mice were stained with FITC-labeled anti-B220 mAb, biotinylated anti-Ly-1 mAb plus PE-streptavidin and analyzed of XID (B6-Ly5.2) mice that had been transferred with lymph node cells from B6-Ly5.1 mice with MAIDS. These cells were MuLV. Single-cell suspensions were prepared from spleens and lymph nodes from infected mice 3-7 weeks after virus stained with FITC-labeled anti-Ly5.1 mAb and biotinylated anti-Ly5.2 mAb plus PE-streptavidin, and then analyzed by a injection. The T cell-depleted, B cell-enriched population was prepared by treating lymph node cells with anti-Thy-1.2
FACScan. mAb (Serotec, Oxford, UK) and guinea pig complement as Detection of Btk mutation previously described (20) . The B cell-depleted, T cell-enriched population was obtained by passage over T cell enrichment Lymph node cells from B6 mice infected with LP-BM5 MuLV 3-7 weeks before the experiment were transferred i.p. into immunocolumns (Biotex, Alberta, Canada). Contamination of separated electrophoretically on 1.5% agarose gels.
weeks after virus inoculation.
Results
the normal range throughout the experimental period of Delayed progression of MAIDS in XID mice reconstituted with 16 weeks. CD5 ϩ B cells from wild-type mice
To evaluate the role of CD5 ϩ B cells in the pathogenesis of MAIDS, we transferred PEC (2ϫ10 6 ) from non-infected B6 We have reported that XID mice show a delayed progression of MAIDS after LP-BM5 MuLV infection. As XID mice lack mice into a group of 13 XID mice. Nine weeks after the cell transfer, three mice were sacrificed. Peritoneal washouts were CD5 ϩ B cells which are the major target cells for defective LP-BM5 MuLV, our results suggested that CD5 ϩ B cells may harvested and examined for their cell surface markers to evaluate reconstitution of CD5 ϩ B cells. Results revealed that play an important role in the progression of the disease (12) . To evaluate this hypothesis, we asked whether the population the proportion of peritoneal B cells expressing CD5 and B220 (R1) in the XID mice was significantly increased (Fig. 2C  of CD5 ϩ B cells is expanded in lymph node and spleen in B6 mice with MAIDS, and then examined whether susceptibility to versus A) and was comparable to non-infected age-matched B6 mice (Fig. 2C versus B) . We then inoculated LP-BM5 MuLV MAIDS in XID mice can be restored by reconstitution of CD5 ϩ B cells from B6 mice. First, we monitored total cell numbers into 10 XID mice which had received the transfer of PEC. As controls, LP-BM5 MuLV was inoculated into a group of agealong with infection in various tissues. As shown in Fig. 1(A) , total cell numbers of spleen, lymph nodes and PEC were matched B6 and XID mice which had not received cells. The development of MAIDS was evaluated 12 weeks after the increased by 5-to 100-fold during the infection period. Then we analyzed the proportion of CD5 ϩ B220 ϩ cells in these virus inoculation. As shown in Table 1 , all B6 mice showed elevated levels of serum IgG2a and progressive lymphadenotissues by flow cytometry using a FACScan and calculated the number of CD5 ϩ B cells. We found an increase in total pathy after virus infection. Slightly increased serum IgG2a was observed in XID mice which had received the cell transfer. numbers of CD5 ϩ B cells in lymph nodes after LP-BM5 MuLV infection (Fig. 1B) , although the increase in the percentages Only two of them showed a slight swelling of inguinal lymph nodes by palpation, while control XID mice did not show any of CD5 ϩ B cells in lymph nodes was marginal. In contrast, the number of CD5 ϩ B cells in the peritoneal cavity decreased swelling of inguinal lymph nodes by the virus inoculation. These results indicated that delayed progression of MAIDS and the total number of CD5 ϩ B cells in spleen remained in mice all mice developed MAIDS-like symptoms represented by a vast elevation of serum IgG2a, an increase in the weight of spleen and lymph node and an impaired Con A responsiveness ( Table 2 ). The severity of MAIDS developed transferred either spleen or lymph node cells (2ϫ10 7 ) from virus-infected B6 mice into XID mice, mice developed MAIDS depended on the number of cells transferred. Furthermore, cell numbers of XID mice required to transmit MAIDS were (Table 3) . The XID mice which received lymph node cells from B6 mice with MAIDS exhibited elevated serum IgG2a greater than that from B6 mice. B6 mice that had received 1ϫ10 5 cells from virus-inoculated XID mice showed marginal and nine out of 10 mice showed lymphadenopathy within 12 weeks of cell transfer. Four out of 10 XID mice which had MAIDS-like symptoms, while B6 mice that received 1ϫ10 4 of cells from virus-infected B6 mice still showed significant received spleen cells showed lymphadenopathy. We did not observe development of MAIDS in XID mice that received immunodeficiency. B6 mice that received cells from noninfected XID or B6 mice did not develop MAIDS (data 1ϫ10 6 lymph node cells from B6 mice with MAIDS (data not shown). Severity of the MAIDS developed in XID mice was not shown). These results indicate that lymphoid cells from asymptomatic XID mice can transmit MAIDS to wild-type mice. similar to that observed in B6 mice which had received 1ϫ10 6 cells from infected B6 mice. XID mice inoculated with LP-BM5 XID mice develop MAIDS after transfer of cells from B6 mice MuLV did not develop lymphadenopathy or splenomegaly 12 with MAIDS weeks after infection, although the serum level of IgG2a was slightly elevated. We then asked whether XID mice fully develop MAIDS when cells from virus-infected B6 mice are transferred. When we Twelve weeks after the transfer of 2ϫ10 7 lymph node cells are able to induce MAIDS development in XID mice.
e Age-matched non-infected mice.
The massive lymphoproliferation and hypergammaglobulinemia expanded in XID mice are derived from XID mice
As described above, XID mice can develop lymphoproliferto XID mice, we prepared a cell suspension from enlarged lymph nodes of the mice with MAIDS, stained them with FITCation when lymph node cells from virus-infected B6 mice are transferred. However, the question remained as to whether labeled anti-B220 and biotinylated anti-Ly-1 mAb plus PEstreptavidin, and analyzed them by a FACScan. The results proliferated cells in the lymph node are of host (XID mice) origin or donor (B6 mice) origin. To address this question, revealed that the proportion of CD5 -B cells was expanded, while the increase in the proportion of CD5 ϩ B220 ϩ cells was total RNA was prepared from enlarged spleen and lymph nodes of XID mice with MAIDS, and a portion of the btk gene marginal (Fig. 3) .
which included the mutation found in XID mice was amplified B cells are responsible for the development of MAIDS in by RT-PCR. We detected the 255 bp PCR products of the btk XID mice gene from both B6 and XID mice ( Fig. 4A and B, lanes 2, 4, 6, 8, 10, and 12). After HaeII digestion, the PCR product from To examine which cell population(s) are responsible for the development of MAIDS in XID mice, we prepared T cellthe wild-type btk gene was cleaved into 45, 46, and 164 bp fragments ( Fig. 4A and B, lane 3) , while that of RNA enriched and B-cell-enriched populations from lymph node cells of B6 mice with MAIDS and transferred them into XID from the XID-type btk gene was cleaved into 46 and 209 bp fragments (Fig. 4B, lane 5) . As shown in Fig. 4 , we observed or B6 mice. As shown in Table 4 We have reported previously that XID mice are resistant to MAIDS, but the resistance in XID mice is not absolute (12) . possibilities are not mutually exclusive.
As we have shown, CD5 ϩ B cells are the major virusinfected B cell population (12) . We inferred from these results XID mice (Fig. 4B, lanes 7, 9, 11 and 13 ). These results that CD5 ϩ B cells might play an important role in the induction indicate that cells expanded from XID mice with MAIDS are and progression of MAIDS and that the lack of CD5 ϩ B cells derived from the XID mice (host origin).
in XID mice might account for the delayed progression of Next, we used two kinds of MAIDS susceptible strains of MAIDS. We examined MAIDS development in XID mice that mice, BALB.B (Igh a allotype) and B6-Ly5.1 mice, as the donor had been i.p. reconstituted with CD5 ϩ B cells from B6 mice. of cells to confirm that cells from XID mice (Igh b allotype/ However, the delayed progression of MAIDS was not affected Ly5.2) can produce large amounts of IgG2a and proliferate in these XID mice (Table 1) . These results provide strong following the transfer of cells from virus-infected B6 mice.
evidence that a lack of CD5 ϩ B cells is not the major reason Both BALB.B and B6-Ly5.1 mice developed MAIDS after LPfor the delayed progression of MAIDS and that conventional BM5 MuLV infection to a similar extent to B6 mice. We did B cells may play a more important role than CD5 ϩ B cells in not observe any mixed lymphocyte reaction responses of the progression of MAIDS. This was ascertained in the present lymphocytes among B6, XID, BALB.B and B6-Ly5.1 mice study by demonstrating that conventional B cells were (data not shown). After transfer of cells from BALB.B mice expanded in XID mice that developed MAIDS (Fig. 2) . with MAIDS, XID mice developed lymphadenopathy, splenoRecently, Tang et al. reported similar findings to us (23) and megary and hypergammaglobulinemia, although the extent suggested that resistance to MAIDS in xid mutants may be of MAIDS development was less than that of B6 mice infected due to the effects of altered conventional B cell function. It with LP-BM5 MuLV (data not shown). XID mice which had still remains a possibility that interaction between CD5 ϩ and received cells from BALB.B mice with MAIDS showed an conventional B cells may be required for MAIDS development, elevation of IgG2a whose allotype was Igh b .
and this interaction might be insufficient in XID mice. At this Then we analyzed the expansion of donor-derived cells moment, we do not have evidence to support this possibility. using a FACScan. We detected Ly 5.1 ϩ cells in the peritoneal One of the most important observations in this study is that washouts, spleen and lymph node (Fig. 5d-f ) of XID mice 1 spleen cells from asymptomatic XID mice are as effective in week after the cell transfer, while the percentages of Ly5.1 ϩ transmitting MAIDS to B6 mice as those from B6 mice with cells in XID mice before the transfer was Ͻ0.3%. Ten weeks MAIDS. These results indicate that asymptomatic XID mice after the cell transfer, XID mice developed MAIDS as the have a sufficient amount of defective virus expression and same extent as B6 mice with LP-BM5 MuLV infection. We also integration to transfer MAIDS to B6 mice, although the detecfound that Ly5.1 ϩ cells in enlarged spleen (Fig. 5g) and lymph tion of the defective virus is marginal. We detected expression node (Fig. 5h) of XID mice were Ͻ0.3%. These results of gag p12 mRNA in XID mice 6 weeks after virus inoculation. indicate that cells involved in hypergammaglobulinemia and
We also detected the defective virus genome by PCR using lymphoproliferation in MAIDS-developed XID mice after the purified DNA from spleen cells of XID mice 3 weeks after cell transfer are derived from XID mice.
infection, although the defective virus mRNA and DNA were not detected in XID mice 1 week after virus inoculation (data Discussion not shown). These results demonstrate that infected cells exist in the virus-inoculated XID mice. Thus, a small number Although the presence of B cells is critical for the development of MAIDS, there are few reports about a causal relationship of cells in XID mice may be infected with defective virus but they may unable to expand in XID mice. This may be one of in future why B cells in XID mice can be expanded in the presence of B cells from virus-infected B6 mice resulting in the main reasons for the delayed progression of MAIDS. Another possibility is that the amount of pathogenic and the development of MAIDS. The experimental system provided in this study will provide a useful tool for the delineation of infectious virus present in cells from the virus-inoculated XID mice is low but may be sufficient to cause disease in B6 mice.
the role of B cells in the development of MAIDS and for the understanding of the B cell abnormality in XID mice. The latter possibility should be re-evaluated in future studies.
The expansion of infected cells and the initial progression of disease may be suppressed in XID mice. XID mice may Acknowledgements lack cells that are required for inducing the expansion of infected cells and the progression of disease. Our analysis We report here that an XID-derived cell population, but not 
